"Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"

CompletedOBSERVATIONAL

Enrollment

1,026

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Alogliptin and Metformin hydrochloride

Alogliptin and Metformin hydrochloride combination tablets

Trial Locations (1)

Takeda Selected Site, Tokyo